NVP-AEW541

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

NVP-AEW541

CAS No. : 475489-16-8

MCE 国际站：NVP-AEW541

产品活性：NVP-AEW541 (AEW541) 是一种有效的 IGF-1R 抑制剂，IC₅₀ 为 0.15 μM，也抑制 InsR，IC₅₀ 为 0.14 μM。

研究领域：Protein Tyrosine Kinase/RTK  |  Autophagy

作用靶点：IGF-1R  |  Insulin Receptor  |  Autophagy

In Vitro: NVP-AEW541 inhibits the in vitro kinase activity of the recombinant IGF-IR kinase domain with an IC50 value of 0.15 μM and to be equipotent against the recombinant InsR kinase domain. NVP-AEW541 is confirmed active toward the IGF-IR kinase (IC₅₀=86 nM) and shown to be selective at the cellular level. Indeed, NVP-AEW541 is found to be 27-fold more potent toward the native IGF-IR, as compared to the structurally related native InsR (IC₅₀=2.3 μM). NVP-AEW541 suppresses the IGF-I-mediated survival, soft agar and proliferation of MCF-7 cells with IC₅₀ of 0.162 μM, 0.105 μM and 1.64 μM, respectively.

In Vivo: Oral administration of NVP-AEW541 (20, 30, or 50 mg/kg) results in abrogation of basal and IGF-I-induced receptor, and PKB and MAPK phosphorylation in the NWT-21 tumor xenograft. NVP-AEW541 is administered by oral gavage [50 mg/kg in 0.2 mL of 25 mM L-(+)-tartaric acid] twice a day for 14 consecutive days. The control group is similarly treated with 0.2 mL carrier [25 mM L-(+)-tartaric acid] twice a day. Tumor volume and animal weight are measured thrice a week till the end of the treatment. At that time, animals are sacrificed and tumors are collected and formalin fixed for histologic and immunohistochemical analyses. In both cases, NVP-AEW541 treatment causes tumor shrinkage that reached the statistical significance (P=0.0156 and P=0.0111 for HTLA-230 and SK-N-BE2c, respectively).

相关产品：Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  Protein Tyrosine Kinase Compound Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Differentiation Inducing Compound Library  |  Endocrinology Compound Library  |  Chemical Probe Library  |  Anti-Pancreatic Cancer Compound Library  |  Angiogenesis-Related Compound Library  |  Anti-Prostate Cancer Compound Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Cytokine Inhibitors Library  |  Cell Death Library  |  Insulin (human)  |  Insulin(cattle)  |  Linsitinib  |  Ceritinib  |  Picropodophyllin  |  BMS-754807  |  S961 acetate  |  GSK1838705A  |  Tranexamic acid  |  BMS-536924  |  AZD-3463  |  GIP, human TFA  |  GSK1904529A  |  MSDC 0160  |  Rhoifolin  |  GIP (3-42), human  |  NVP-ADW742  |  NVP-TAE 226  |  PQ401  |  AG1024  |  GIP (1-30) amide,human acetate  |  XL228  |  Ganitumab  |  Ginsenoside Rg5  |  BCTC  |  Insulin glargine  |  AVJ16  |  NBI-31772

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds